Transcriptional regulation of polycyclic aromatic hydrocarbon metabolism
多环芳烃代谢的转录调控
基本信息
- 批准号:8388807
- 负责人:
- 金额:$ 27.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-01 至 2014-11-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorCarcinogensCell LineChemically Induced ToxicityCytochromesDNA AdductsDataDiabetes MellitusDiseaseDrug Metabolic DetoxicationDyslipidemiasEnzymesEquilibriumEventExposure toGenesGenetic PolymorphismGenetic TranscriptionHumanLeadMalignant NeoplasmsMediatingMetabolic ControlMetabolismMolecularObesityPathway interactionsPeroxisome Proliferator-Activated ReceptorsPhasePredispositionProteinsReceptor SignalingRegulationRoleSignal TransductionSkinSkin CarcinogenesisToxic effectTranscriptional RegulationUp-RegulationVariantXenobiotic MetabolismXenobioticscarcinogenesischemical carcinogenchemical carcinogenesiscostenvironmental chemicalin vivo Modelkeratinocytenovelpreventpublic health relevancereceptorresponse
项目摘要
DESCRIPTION (provided by applicant): Polycyclic aromatic hydrocarbons (PAH) are a class of environmental chemicals that are known to cause toxicity and cancers in humans. The molecular changes induced by exposure to PAH are mediated by the aryl hydrocarbon receptor (AHR). In particular, the AHR mediates up-regulation of phase I and phase II xenobiotic metabolizing enzymes that can cause both bioactivation and detoxification of PAH. Indeed, there is a fine balance between bioactivation and detoxification of chemical carcinogens that are directly influenced by AHR-dependent signaling. Emerging evidence indicates that PPAR?/? may modulate AHR activity in skin/keratinocytes, and that this interaction will significantly alter the balance between bioactivation and detoxification leading to differences in the susceptibility to chemically-induced toxicity. For Specific Aim 1, we will determine the mechanisms by which PPAR?/? can modulate AHR activity with an emphasis on receptor heterodimer translocation and critical transcriptional events necessary for increasing expression of xenobiotic metabolism that are necessary for bioactivation and detoxification of PAH. For Specific Aim 2, we will determine if PPAR?/? can functionally alter PAH-induced skin carcinogenesis mediated by AHR. Results from these studies will elucidate novel regulatory mechanisms of AHR-dependent signaling that are central in mediating the toxic and carcinogenic effects caused by exposure to environmental PAH. Importantly, results from these studies might help explain the significant variation in AHR-dependent function in humans, since no functional polymorphisms in the Ahr have been identified.
描述(由申请人提供):多环芳烃(PAH)是一类环境化学物质,已知会引起人类毒性和癌症。暴露于PAH引起的分子变化是由芳基烃受体(AHR)介导的。特别是,AHR介导了I期和II期异种生物代谢酶的上调,这些酶可能引起PAH的生物活化和排毒。实际上,直接受AHR依赖性信号传导影响的化学致癌物的生物活化与解毒之间存在良好的平衡。新兴证据表明PPAR?/?可能调节皮肤/角质形成细胞中的AHR活性,并且这种相互作用将显着改变生物活化和排毒之间的平衡,从而导致化学诱导毒性的易感性差异。对于特定目标1,我们将确定哪种PPAR的机制?/?可以调节AHR活性,重点是受体异二聚体易位以及增加生物活化和PAH排毒所必需的异生物代谢表达所必需的关键转录事件。对于特定的目标2,我们将确定PPAR是否?/?在功能上可以改变PAH诱导的皮肤致癌作用,AHR介导。这些研究的结果将阐明AHR依赖性信号传导的新型调节机制,这些机制是介导由环境PAH引起的毒性和致癌作用的中心。重要的是,这些研究的结果可能有助于解释人类AHR依赖性功能的显着差异,因为尚未鉴定出AHR中的功能多态性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jeffrey M Peters其他文献
2022-2023 Toxicological Sciences: Paper of the Year.
2022-2023 毒理学科学:年度论文。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.8
- 作者:
Yvonne Will;Jeffrey M Peters - 通讯作者:
Jeffrey M Peters
Jeffrey M Peters的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jeffrey M Peters', 18)}}的其他基金
Modulation of liver cancer by PPARbeta/delta
PPARbeta/delta 对肝癌的调节
- 批准号:
8255562 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Transcriptional regulation of polycyclic aromatic hydrocarbon metabolism
多环芳烃代谢的转录调控
- 批准号:
8196719 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Modulation of liver cancer by PPARbeta/delta
PPARbeta/delta 对肝癌的调节
- 批准号:
8658016 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Transcriptional regulation of polycyclic aromatic hydrocarbon metabolism
多环芳烃代谢的转录调控
- 批准号:
7789847 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Modulation of liver cancer by PPARbeta/delta
PPARbeta/delta 对肝癌的调节
- 批准号:
8461642 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Modulation of liver cancer by PPARbeta/delta
PPARbeta/delta 对肝癌的调节
- 批准号:
8081851 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Transcriptional regulation of polycyclic aromatic hydrocarbon metabolism
多环芳烃代谢的转录调控
- 批准号:
8010958 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Modulation of liver cancer by PPARbeta/delta
PPARbeta/delta 对肝癌的调节
- 批准号:
7992489 - 财政年份:2010
- 资助金额:
$ 27.48万 - 项目类别:
Modulation of AhR-dependent signaling by PPARb/d
PPARb/d 对 AhR 依赖性信号传导的调节
- 批准号:
7580085 - 财政年份:2009
- 资助金额:
$ 27.48万 - 项目类别:
Modulation of AhR-dependent signaling by PPARb/d
PPARb/d 对 AhR 依赖性信号传导的调节
- 批准号:
7895052 - 财政年份:2009
- 资助金额:
$ 27.48万 - 项目类别:
相似海外基金
Hepatic Aryl Hydrocarbon Receptor Regulation of Obesity: Mechanisms of Action
肝芳基烃受体对肥胖的调节:作用机制
- 批准号:
10701901 - 财政年份:2022
- 资助金额:
$ 27.48万 - 项目类别:
Mechanisms Controlling Sensitivity and Resistance to Dioxin-like Compounds: Role of AIP
控制对二恶英类化合物的敏感性和耐受性的机制:AIP 的作用
- 批准号:
10538943 - 财政年份:2022
- 资助金额:
$ 27.48万 - 项目类别:
Investigating a Model for PM-Induced Exacerbation of Autoimmunity
研究 PM 诱发的自身免疫恶化模型
- 批准号:
9974282 - 财政年份:2019
- 资助金额:
$ 27.48万 - 项目类别:
Investigating a Model for PM-Induced Exacerbation of Autoimmunity
研究 PM 诱发的自身免疫恶化模型
- 批准号:
10477272 - 财政年份:2019
- 资助金额:
$ 27.48万 - 项目类别:
Investigating a Model for PM-Induced Exacerbation of Autoimmunity
研究 PM 诱发的自身免疫恶化模型
- 批准号:
10266063 - 财政年份:2019
- 资助金额:
$ 27.48万 - 项目类别: